News

More Americans “priced out of the system,” survey finds.

This week's edition of the Mainstream Patients features stories about the difference between a sun burn and sun poisoning, micro-coring, and more.

ICYMI, this week we had stories on the latest coverage from the 2022 American Academy of Dermatology Annual meeting, our newest drug pipeline video and more.

Creating a heterogenous cohort in pediatric clinical trials aids in the generalizing of the results and helps ensure that data of efficacy and safety are more accurate. A report looks at data from the past 10 years to see how often race/ethnicity are reported and whether there has been improved inclusion of non-White children.

This week's edition of the Mainstream Patients features stories about skin of color dermatology, a deep dive on hair loss, and more.

Click here to answer this week's poll.

ICYMI, this week we had stories on the latest coverage from the 2022 American Academy of Dermatology Annual meeting, coverage from the 18th Annual Skin of Color Symposium, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses how treatments are often too expensive for patients, which causes them to be labeled as “non-compliant.” He discusses ways to improve adherence for both patients and doctors

Vial Dermatology CRO announced that the associate professor of dermatology and rheumatology at Harvard Medical School and the vice chair of clinical trials and innovation at Brigham and Women's Hospital in Boston, Massachusetts, has joined its Scientific Advisory Board.

Physicians have a role in stamping out weight bias.

More hikes expected to help slow rising inflation.

Implementation challenges and loopholes limit laws’ impact.

ICYMI, this week we had stories on the genetics of acne, FDA warnings, and more.

A recent study examined the main reasons why patients in the United States seek care from dermatologists.

The results of physician trials led by the AAFP Innovation Lab are very promising.

ICYMI, this week we had stories on new data on pembrolizumab, Amyrt receiving a Complete Response Letter (CRL) for Oleogel-S10, and more.

Vial announced another addition to their CRO with David Pariser, MD, FACP, FAAD.

This weekend, March 11-13, 2022, the San Diego Dermatology Symposium (SDDS) will be educating physicians in person. Everything from traditional topics like atopic dermatitis to rare disease such as Stevens-Johnson syndrome will be covered.

Click here to answer this week's poll.

ICYMI, this week we had stories on the trending skin care in February, a new podcast episode, and more.

'Alexa, I want to talk to a doctor’

Emergency department visits are a big contributor.

Medicare Advantage program enrollment grows 9 percent for 2022.

Vial Dermatology CRO announced that Mark Lebwohl, MD, a Dermatology Times® Board member, as an addition to its dermatology CRO, which was launched earlier this year.

Almost a quarter are thinking about leaving health care after two years of a pandemic.

ICYMI, this week we had stories on the stagnant diversity in dermatology clinical trials, skin cancer risk for incarcerated patients, and more.

The American Academy of Dermatology meeting, held in Boston, Massachusetts this year, will not be requiring those in attendance to prove their COVID-19 vaccination status.

Many will be forced to forgo care or return to the workforce to pay health care bills

Data shows some encouraging trends, but filling positions proving difficult with costs increasing

An article in JAMA Dermatology examines if any changes have been made to the diversity of dermatologic clinical trials conducted from 2010 to 2015 compared to 2015 to 2020. While reporting of racial and ethnic data has become more transparent, inclusion remains a struggle.